The first four draws cannot be said to be good, but they feel okay. Bai Ye may have thought these things were a bit wasteful in the past, but giving them to Bai Ye now is equivalent to giving Bai Ye a new development field.
In the field of food research and development, Bai Ye is now considering whether it is necessary to open a research institute to specialize in food research, and then establish a food group. If this is done, he will have the opportunity to become the world's richest man?
After thinking about it clearly, Bai Ye felt that there was still something very promising. He made a prompt decision. He picked up paper and pen and decided to put this matter in a memo and include it as one of the key things to study next.
Although food and medicine are two different things, people who have been accustomed to medicine for a long time can easily feel at ease when making food. After all, medicine approval is strict, while food is much more relaxed.
There is still the last lottery left, the six-star lottery. Bai Ye doesn't know what will be given to him, but he is still looking forward to it.
It's best if it's not a trainload of drinks.
Otherwise, at the end of the year, the company’s welfare should not be money, but drinks...
Thinking of this, Bai Ye rubbed his hands and started the lottery directly.
[Ding! Congratulations on obtaining ngs technology!]
When Bai Ye heard this voice, his heart was filled with tears.
ngs technology!
This is the ngs technology that Considin mentions every day!
Bai Ye felt very excited and excited just thinking about it.
Bai Ye suddenly lost his instinctive reason after seeing these three letters.
What is ngs?
Perhaps most people don't quite understand it, but after the last study on intestinal cancer, Bai Ye completed the make-up course on genetic engineering technology in an instant, and also made great progress and understanding of many professional terms and nouns.
The system gave an accurate answer:
[The full name of ngs technology: high-throughput sequencing technology, also known as "next-generation" sequencing technology, can perform parallel processing on hundreds of thousands to millions of DNA molecules at a time.
Sequence determination and generally short read length are signs.】
High-throughput sequencing technology is a revolutionary change to traditional sequencing. It can sequence hundreds of thousands to millions of DNA molecules at a time. Therefore, it is called next generation sequencing technology (next generation sequencing) in some literatures.
An epoch-making change, and high-throughput sequencing makes it possible to conduct a detailed and comprehensive analysis of the transcriptome and genome of a species, so it is also called deep sequencing.
It can be said that the birth of high-throughput sequencing technology is a landmark event in the field of genomics research.
This technology has caused the cost of a single base of nucleic acid sequencing to drop sharply compared with the first generation sequencing technology. Taking human genome sequencing as an example, the Human Genome Project at the end of the last century cost 3 to 10 billion US dollars to decode the code of human life.
Generation sequencing has brought human genome sequencing into the era of multi-million dollar genomes.
Such a low cost of single-base sequencing allows us to implement genome projects for more species and decipher the genetic code of the genomes of more biological species. At the same time, among species that have completed genome sequencing, we can conduct large-scale sequencing of other species of the species.
Whole-genome resequencing has also become possible.
The most critical thing is not his sequencing, but what?
NGS technology is a particularly big difficulty in the development of SCS (single cell sequencing) technology.
This difficulty directly limits the development of single-cell sequencing technology.
Single-cell sequencing technology is the most popular technology of Considin Laboratory. It can use next-generation sequencing and ngs technology to observe the genetic sequence information of single cells, thereby obtaining the differences in genetic material and protein information between cells. Therefore,
It can better understand the functions of a single small number of cells in their microenvironment.
By sequencing the entire genome, transcriptome, and cell expression genes of individual tumor cells, it is possible to reveal the complex mechanisms within tumor cells.
Currently, single cell sequencing technology, also known as SCS technology, is the world's leading cancer research and development technology. It is also the most popular technology of Mr. Considin. He can be said to be very good in this industry.
Last time, it was precisely because of the help of Considine and Morstan that Bai Ye and the others continued to accelerate their research progress.
At that time, Bai Ye clearly remembered that Considin said that if the high-throughput sequencing technology - ngs technology could develop rapidly, his single-cell sequencing technology would definitely shine.
He even believes that high-throughput sequencing technology is even a key technology for future development!
This involves a function of genetic engineering and tumor prevention.
After all, the combination of high-throughput measurement technology and single-cell sequencing technology can predict the development direction and trend of the next generation of cells, which is of great help to cells.
Bai Ye took a deep breath to calm down his inner excitement.
What a baby!
With such a technology at hand, what else do you have to worry about?
Although ngs single-cell sequencing technology is difficult, Bai Ye also learned a lot, especially relying on those expensive instruments, Bai Ye can also try it.
Besides, John is also a master in the field of genetics. If someone else has some good technology, wouldn't it be a perfect thing for Yang?
Bai Ye got up excitedly and walked back and forth, feeling happy inside.
Roche Group, let’s compete this time to see who can win.
Originally, Bai Ye was worthy of the Roche Group, but now that he has NGS high-throughput sequencing technology, he is no longer timid.
No matter how strong Bona and the others are, Bai Ye is not afraid at all.
At this time, a meeting was being held within the Implementation Group, and this meeting summoned all Roche's top management.
But only seven people sat at the front.
Among these seven people are three former members of the research and development team of the drug Proxicon: Bona, Considine, and Mostan.
The other four people did not feel awkward or unnatural sitting with the three of them, because their status was not inferior to Bona and others.
The Luo Group is what it is today, naturally it does not rely on vain things, it relies on strength.
This time, the Roche Group invited the last two or three Nobel Prize winners, some of the more recent ones in the field of cytology.
With these seven great members joining at the same time, plus the lineup of academicians, it can be said that this time the Roche Group paid a heavy price for this cancer research.
In fact, after the Luo Group was rejected by Bai Ye, they made up their minds to do it themselves.
To this end, he spent a lot of money to invite Bona and others. As for the means, they were not important.
They are even ready for a showdown.
The Roche Group is able to reach this day, so naturally it will not be intimidated by a newcomer. It is able to compete evenly with Pfizer and still be able to survive until now. He does not rely on luck, but on strength!